Thomas F. Ryan Jr., Director at REPLIGEN CORP (RGEN), sold 6,190 shares at $151.77 ($940K) on 2020-07-31, disclosed to the SEC on 2020-08-04.
Open-market sale of $940k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.77 | 986 | $150K | 15.9% |
| 2 | $151.77 | 986 | $150K | 15.9% |
| 3 | $151.96 | 2,109 | $320K | 34.1% |
| 4 | $151.96 | 2,109 | $320K | 34.1% |
| Total | $151.90 avg | 6,190 | $940K | 100% |
| Filing → |
| RGEN | SELL | 2021-08-05 | $195K | — | Filing → |
| RGEN | SELL | 2021-03-04 | $205K | — | Filing → |
| RGEN | SELL | 2020-11-13 | $351K | — | Filing → |